Selegiline
Selegiline, a synthetic phenethylamine derivative, is classified as a selective, irreversible monoamine oxidase B (MAO-B) inhibitor. Initially synthesized in the 1960s, its biological significance lies in its capacity to modulate central nervous system neurotransmission. Physiologically, selegiline primarily functions by inhibiting MAO-B, an enzyme responsible for the oxidative deamination and subsequent breakdown of neurotransmitters, particularly dopamine, within the brain. This selective inhibition leads to a sustained increase in dopamine levels in the synaptic clefts, enhancing dopaminergic signaling. Clinically, selegiline is a well-established medication, predominantly utilized as an adjunctive therapy in the early stages of Parkinson's disease to improve motor symptoms and potentially exert neuroprotective effects by reducing oxidative stress associated with dopamine metabolism. A transdermal patch formulation is also approved for the treatment of major depressive disorder. Ongoing research continues to investigate selegiline's broader neuroprotective capabilities, its influence on neuronal survival pathways, and its potential therapeutic utility in other neurodegenerative conditions, such as Alzheimer's disease, underscoring its complex pharmacological profile.
Navigate sections
Form & Dosage
Selegiline Transdermal Patch (Emsam)
The transdermal patch delivery system for selegiline (marketed as Emsam) bypasses first-pass metabolism, allowing for higher bioavailability of the parent compound and reduced formation of amphetamine metabolites. This form is primarily used for major depressive disorder. At lower doses, it can be used without the strict dietary restrictions typically required for oral MAOIs, as it preferentially inhibits MAO-B in the brain without significantly affecting peripheral MAO-A.
Apply the transdermal patch to a clean, dry area of skin on the upper torso, thigh, or upper arm, rotating sites daily to minimize skin irritation. Do not apply to skin that is cut, irritated, or oily. The patch provides a continuous, steady release of medication, bypassing the digestive system and reducing the formation of stimulating metabolites compared to oral forms. While lower doses (e.g., 6 mg/24h) may not require strict dietary restrictions, higher doses (e.g., 9 mg/24h or 12 mg/24h) still necessitate avoiding tyramine-rich foods to prevent hypertensive crisis. Always follow your doctor's specific instructions for patch application and dietary considerations.
Effects (16)
Bioavailability Improvement
The transdermal patch significantly improves selegiline's bioavailability by bypassing liver first-pass metabolism, ensuring a higher and more consistent delivery of the active compound to the bloodstream and brain compared to oral administration.
Dopamine System Support
Selegiline directly supports the dopamine system by inhibiting MAO-B, an enzyme that breaks down dopamine in the brain, leading to increased and prolonged dopamine signaling crucial for motivation, mood, and motor control.
Motivation Increase
Selegiline boosts motivation by increasing dopamine availability in brain regions responsible for reward and drive, making it easier to initiate tasks and pursue goals for many users.
Fatigue Reduction
Selegiline helps combat fatigue by enhancing dopaminergic signaling and providing a mild stimulating effect, leading to increased alertness and sustained vitality.
Increased Mental Productivity
As a result of enhanced focus and motivation, selegiline can significantly boost mental productivity, enabling users to complete tasks more efficiently and with greater cognitive clarity.
Physical Energy Boost
By increasing brain dopamine and, particularly with the oral form, generating stimulant metabolites, selegiline can significantly boost physical energy levels and reduce feelings of fatigue throughout the day.
Concentration Improvement
Selegiline enhances concentration by optimizing dopamine levels in the prefrontal cortex, which is vital for sustained attention and the ability to focus on tasks without distraction.
Increase Mental Endurance
Selegiline extends mental endurance by preserving dopamine levels, which helps sustain cognitive performance and resilience against mental fatigue during prolonged periods of demanding intellectual work.
Serotonin System Support
At appropriate doses, selegiline supports the serotonin system by inhibiting MAO-A, leading to increased serotonin availability in the brain, a key factor in mood regulation and antidepressant effects.
Antidepressant Effect
Selegiline acts as an antidepressant by modulating dopamine, norepinephrine, and serotonin levels in the brain through MAO inhibition, which helps alleviate symptoms of depression and improve overall mood. While both forms can be used, the transdermal patch is often preferred for its more favorable side effect profile. This effect typically builds over several weeks.
Neuroprotective Effect
Selegiline exhibits neuroprotective effects by reducing oxidative stress and inhibiting neuronal apoptosis, contributing to the preservation of brain cells and potentially slowing neurodegenerative processes over extended periods of use.
Improving neuroplasticity
Selegiline is theorized to support neuroplasticity by influencing neuronal growth and synaptic strength, potentially aiding the brain's ability to adapt and learn over extended periods, although this effect is not directly felt by users.
Mood Improvement
By subtly enhancing dopamine signaling, selegiline can contribute to an uplifted mood and reduced anhedonia, often noticeable within days for some users, improving overall emotional well-being.
Brain Fog Reduction
By enhancing brain dopamine and general alertness, selegiline can help clear mental 'fog', leading to sharper thinking and improved cognitive clarity for many users.
Morning Alertness Improvement
By subtly increasing dopaminergic activity and providing a mild stimulant effect, selegiline can improve alertness upon waking, helping users feel more clear-headed and ready to start the day.
Memory Improvement
By indirectly supporting cognitive functions through optimized dopamine levels, selegiline can subtly enhance aspects of memory, particularly those related to attention and information processing over time.
Side Effects (17)
Increased Blood Pressure (Hypertension)
At higher doses, Selegiline loses its MAO-B selectivity and inhibits MAO-A, leading to a significant risk of hypertensive crisis if tyramine-rich foods are consumed. This risk is lower with the transdermal patch at recommended doses but remains a concern with higher patch strengths or oral formulations.
Insomnia
Selegiline's stimulating effect, especially from its amphetamine metabolites or direct dopamine increase, can disrupt your sleep cycle, making it harder to fall asleep or stay asleep, particularly if taken later in the day.
Skin Rash / Irritation
As a transdermal patch, local skin irritation, redness, or a rash at the application site are common occurrences, though usually mild and temporary.
Nausea
Some individuals may experience an unsettled stomach or nausea, especially when first starting Selegiline or if taken on an empty stomach.
Headache
A mild headache can occur as your body adjusts to the changes in neurotransmitter levels, a common initial side effect with many CNS-acting medications.
Appetite Changes (Undesirable)
The stimulating effects, particularly from Selegiline's amphetamine metabolites, can suppress appetite, potentially leading to unintended weight loss for some users.
Increased Sweating
An increase in perspiration, or hyperhidrosis, can be a minor side effect due to the supplement's impact on the autonomic nervous system.
Dizziness
Feelings of lightheadedness or dizziness, particularly when standing up quickly, can occur due to Selegiline's effect on blood pressure regulation.
Constipation
Some users may experience digestive sluggishness, leading to infrequent or difficult bowel movements, as a general systemic effect of the supplement.
Nervousness and Restlessness
Some individuals may experience an unsettling feeling of inner tension, anxiety, or an inability to sit still, attributable to Selegiline's stimulating properties.
Dry Mouth (Xerostomia)
Reduced saliva production, leading to a dry sensation in the mouth, is a reported side effect that can occur with Selegiline use.
Tachycardia
An elevated heart rate, felt as palpitations, can occur due to the stimulating effects of Selegiline and its metabolites, similar to other CNS stimulants.
Confusion
In rare cases, especially in sensitive individuals or at higher doses, Selegiline can cause disorientation or difficulty concentrating, leading to a state of confusion.
Hallucinations
While rare, Selegiline's impact on dopamine levels can, in some susceptible individuals or at very high doses, trigger visual or auditory hallucinations, particularly when combined with other dopaminergic medications.
Dyskinesia
Involuntary, uncontrolled movements, known as dyskinesia, can occur as a rare side effect, especially in Parkinson's patients taking Selegiline alongside levodopa, due to excessive dopamine stimulation.
Decreased Libido
A decrease in sexual desire can be an occasional side effect, as Selegiline's modulation of dopamine and other neurotransmitters might affect libido in some individuals.
Ejaculation Disorder
Though uncommon, changes in ejaculation, such as delayed or absent ejaculation, can occur due to Selegiline's effects on neurotransmitters involved in sexual function.
Indications
- + Depression
- + Cognitive Decline / Reduced Mental Performance
- + Parkinson's Disease
Contraindications
- - Bipolar Disorder (Manic Phase)
- - Pheochromocytoma
- - Seizure Disorders / Epilepsy
- - Heart Arrhythmia
- - Kidney Disease
Synergies
Antagonists
Restrictions
- ! Not recommended for pregnant women
- ! Not recommended for breastfeeding women
- ! Not recommended for children
The transdermal patch form of Selegiline (Emsam) is a prescription medication. It should not be used concurrently with other MAOIs, SSRIs, SNRIs, tricyclic antidepressants, or certain sympathomimetic agents due to the risk of serotonin syndrome or hypertensive crisis. Although the patch significantly reduces first-pass metabolism, doses above 6 mg/24h may still require dietary restrictions on tyramine-rich foods. Discontinue use and seek medical attention immediately if signs of a hypertensive crisis (severe headache, stiff neck, nausea, vomiting, sweating) or serotonin syndrome (agitation, hallucinations, rapid heart rate, fever) occur. Not recommended for use during pregnancy or breastfeeding, or in children.